Biomerieux Inc recalls
4 notices naming Biomerieux Inc as the recalling firm, since October 8, 2025. A notice covers specific products and lots, not every product of the firm.
Hazard and remedy text is quoted from the agency, unedited. The tag names the kind of risk with a word from that text. Every notice links to its official page.
Biomerieux Inc: VITEK 2 AST-N461 TEST KIT
Hazard (FDA): The issue is related to card pouch damage associated with a portion of the lot which was produced on a specific card pouching device, in a specific timeframe, causing a potential risk of false resistant results. False…
FDAMedical devices
Biomerieux Inc: VITEK 2 AST-N447 TEST KIT Product reference 424620
Hazard (FDA): Potential for false resistant carbapenem and/or cephalosporin results when analyzing samples with kits from affected lot that have pouch foil fractures.
FDAMedical devices
Biomerieux Inc: VITEK 2 Gram-negative Susceptibility Cards Containing o Polymyxin B
Hazard (FDA): Potential risk of Quality Control failures and/or false resistant antibiotic results when testing isolates of Enterobacterales/Enterobacteriaceae species and/or Pseudomonas aeruginosa with the identified antibiotic…
FDAMedical devices
bioMerieux, Inc.: VITEK¿ 2 Gram-negative AST Test Kits
Hazard (FDA): Potential for false resistant results for Colistin (cs02n) with multi-drug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii complex used in specific cards
FDAMedical devices